Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
Objective: To determine if atomoxetine 40 mg bid (bis in die) in patients ≥18 years old with recurrent vasovagal syncope will better prevent syncope during tilt testing than placebo.
Epistemonikos ID: f9fdb145339f60f1b844fdf019ed4bd48dcd0ae8
First added on: May 12, 2024